Bharat Bio’s Telangana unit failed GMP test, led to Covaxin suspension: WHO

NEW DELHI: It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech‘s flagship vaccine manufacturing facility at Hyderabad‘s Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement.

Confirming this, WHO told TOI that the inspection it had carried out between March 14 and 22 “found that the manufacturing site for the production of the Covid vaccine Covaxin, located in Telangana, India, is not compliant with GMP and systemic issues need to be addressed”. “Problems were detected in some parts of the manufacturing process and changes were made after the EUL (emergency use listing) was granted but were not submitted to the national drug regulator and WHO for evaluation. The inspection was part of an campaign of manufacturing sites in India,” WHO said.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 236 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 309 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra